RenovoRx (RNXT) Profit After Tax (2024 - 2025)

RenovoRx (RNXT) has disclosed Profit After Tax for 2 consecutive years, with -$3.4 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax fell 35.34% to -$3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$11.7 million through Dec 2025, down 37.62% year-over-year, with the annual reading at -$12.1 million for FY2025, 14.14% down from the prior year.
  • Profit After Tax hit -$3.4 million in Q4 2025 for RenovoRx, down from -$2.9 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$1.1 million in Q1 2024 to a low of -$3.4 million in Q4 2025.